Sterba J - Search Results

1

Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.

Vejmelkova K, Pokorna P, Noskova K, Faustmannova A, Drabova K, Pavelka Z, Bajciova V, Broz M, Tinka P, Jezova M, Palova H, Kren L, Valik D, Slaby O, Sterba J. Vejmelkova K, et al. Among authors: sterba j. Sci Rep. 2023 Dec 7;13(1):21623. doi: 10.1038/s41598-023-48774-2. Sci Rep. 2023. PMID: 38062114 Free PMC article.

2

Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors.

Sterba J, Pavelka Z, Slampa P. Sterba J, et al. Neoplasma. 2002;49(2):117-20. Neoplasma. 2002. PMID: 12088104 Clinical Trial.

3

Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy.

Valik D, Radina M, Sterba J, Vojtesek B. Valik D, et al. Among authors: sterba j. Pharmacogenomics. 2004 Dec;5(8):1151-62. doi: 10.1517/14622416.5.8.1151. Pharmacogenomics. 2004. PMID: 15584881 Review.

4

[What is your diagnosis? Answer: Ependymoma, cellular and clear cell variant].

Kren L, Sterba J. Kren L, et al. Among authors: sterba j. Cesk Patol. 2005 Apr;41(2):59, 79. Cesk Patol. 2005. PMID: 15966334 Czech. No abstract available.

5

Chylothorax as a possible diagnostic pitfall: a report of 2 cases with cytologic findings.

Kren L, Rotterova P, Hermanova M, Krenova Z, Sterba J, Dvorak K, Goncharuk V, Wilner GD, McKenna BJ. Kren L, et al. Among authors: sterba j. Acta Cytol. 2005 Jul-Aug;49(4):441-4. doi: 10.1159/000326181. Acta Cytol. 2005. PMID: 16124177

6

Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate.

Valik D, Sterba J, Bajciova V, Demlova R. Valik D, et al. Among authors: sterba j. Oncology. 2005;69(3):269-72. doi: 10.1159/000088334. Epub 2005 Sep 15. Oncology. 2005. PMID: 16166815

7

Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.

Sterba J, Prochazka J, Ventruba J, Kren L, Valik D, Burgetova D, Mudry P, Skotakova J, Blatny J. Sterba J, et al. Pediatr Hematol Oncol. 2005 Dec;22(8):649-55. doi: 10.1080/08880010500278665. Pediatr Hematol Oncol. 2005. PMID: 16251170

8

High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?

Sterba J, Valík D, Bajciová V, Kadlecová V, Gregorová V, Mendelová D. Sterba J, et al. Neoplasma. 2005;52(6):456-63. Neoplasma. 2005. PMID: 16284689 Review.

9

Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.

Sterba J, Dusek L, Demlova R, Valik D. Sterba J, et al. Clin Chem. 2006 Apr;52(4):692-700. doi: 10.1373/clinchem.2005.061150. Epub 2006 Feb 2. Clin Chem. 2006. PMID: 16455868

10

Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study.

Sterba J, Valik D, Mudry P, Kepak T, Pavelka Z, Bajciova V, Zitterbart K, Kadlecova V, Mazanek P. Sterba J, et al. Onkologie. 2006 Jul;29(7):308-13. doi: 10.1159/000093474. Epub 2006 Jul 3. Onkologie. 2006. PMID: 16874014 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters